Status:
UNKNOWN
GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral Centers
Lead Sponsor:
Regina Elena Cancer Institute
Collaborating Sponsors:
Candiolo Cancer Institute - IRCCS
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale
Conditions:
Sarcoma
Eligibility:
All Genders
Brief Summary
Multicenter noninterventional, translational study, retrospective/prospective designed in order to assess the aptitude to the use of genomic profiling methods for therapeutic purposes and evaluation b...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Sarcoma patients of any age (inclusion of centers pediatric)
- Patients with any histotype of soft tissue sarcomas and bone
- Patients at any stage of the treatment pathway for disease that is localized or metastatic/inoperable
- Availability of follow-up data
- Written informed consent (prospective part/patients in follow-up)
Exclusion
Key Trial Info
Start Date :
May 25 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 25 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06076070
Start Date
May 25 2022
End Date
May 25 2024
Last Update
October 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
"Regina Elena" National Cancer Institute
Rome, Italy, 00144